title: Differential effects of Nucleostemin suppression on cell cycle arrest and apoptosis in the bladder cancer cell lines 5637 and SW1710.
abstract: OBJECTIVE
  The Nucleostemin (NS) gene encodes a nucleolar protein enriched in adult and embryonic stem cells. NS is thought to regulate cancer cell proliferation, but the mechanisms involved are poorly understood. In this study, we have investigated the role of NS in bladder cancer.
  
  
  METHODS
  Expression of NS was determined by quantitative reverse transcription-polymerase chain reaction in bladder carcinoma cell lines and in normal uro-epithelial cell cultures. We used an RNAi strategy to investigate the function of NS in two selected carcinoma cell lines.
  
  
  RESULTS
  High NS expression was found in most bladder carcinoma cell lines and normal uro-epithelial cells. Knockdown of NS expression induced a severe decline in cell proliferation in 5637 and SW1710 cell lines, both with mutant p53. Apoptosis was more strongly enhanced in 5637 cells lacking RB1 than in SW1710 cells lacking p16(INK4A). Moreover, NS-siRNA-treated 5637 cells accumulated mainly in G(2)/M, whereas SW1710 cells arrested in G(0)/G(1).
  
  
  CONCLUSIONS
  Our data indicate that NS expression is necessary for cell proliferation and evasion of apoptosis in bladder cancer cells, independent of its effect on p53. Also, we speculate that the precise effect of NS on cell cycle regulation may relate to functional status of RB1 and CDKN2A/p16(INK4A).
authors.affiliation: Department of Genetics, Faculty of Basic Sciences, Tarbiat Modares University, Tehran, Iran.
authors.forename: P
authors.initials: P
authors.lastname: Nikpour
authors.forename: S J
authors.initials: SJ
authors.lastname: Mowla
authors.forename: S M
authors.initials: SM
authors.lastname: Jafarnejad
authors.forename: U
authors.initials: U
authors.lastname: Fischer
authors.forename: W A
authors.initials: WA
authors.lastname: Schulz
mesh_terms: D017209:Apoptosis / Q000235:genetics*; D015153:Blotting, Western; D002352:Carrier Proteins / Q000235:genetics / Q000502:physiology*; D002453:Cell Cycle / Q000235:genetics*; D045744:Cell Line, Tumor; D015536:Down-Regulation; D019204:GTP-Binding Proteins; D055785:Gene Knockdown Techniques; D006801:Humans; D020125:Mutation, Missense; D009687:Nuclear Proteins / Q000235:genetics / Q000502:physiology*; D034622:RNA Interference; D020133:Reverse Transcriptase Polymerase Chain Reaction; D001749:Urinary Bladder Neoplasms / Q000235:genetics / Q000473:pathology*
chemical_list: D002352:Carrier Proteins; C469949:GNL3 protein, human; D009687:Nuclear Proteins; D019204:GTP-Binding Proteins
references.citation: Cancer Res. 2001 Sep 1;61(17):6340-4
references.pmid: 11522622
references.citation: Mol Cell Biol. 2008 Jul;28(13):4365-76
references.pmid: 18426907
references.citation: J Clin Oncol. 2006 Dec 10;24(35):5552-64
references.pmid: 17158541
references.citation: Rejuvenation Res. 2008 Apr;11(2):379-86
references.pmid: 18399786
references.citation: Br J Cancer. 1995 Sep;72(3):683-90
references.pmid: 7669581
references.citation: Mol Cell Biol. 2006 Dec;26(24):9291-301
references.pmid: 17000755
references.citation: Cancer Res. 1998 Dec 1;58(23):5348-53
references.pmid: 9850064
references.citation: Chin Med J (Engl). 2008 Feb 20;121(4):299-304
references.pmid: 18304460
references.citation: Br J Cancer. 2006 Jun 5;94(11):1658-62
references.pmid: 16670719
references.citation: Front Biosci. 2007 Jan 01;12:2233-51
references.pmid: 17127460
references.citation: Mol Biol Cell. 2005 Jul;16(7):3401-10
references.pmid: 15857956
references.citation: Exp Cell Res. 2003 Jan 1;282(1):48-57
references.pmid: 12490193
references.citation: Mol Cell Biol. 2006 Dec;26(24):9279-90
references.pmid: 17000763
references.citation: Genes Chromosomes Cancer. 2000 Mar;27(3):252-63
references.pmid: 10679914
references.citation: Blood. 2007 Nov 15;110(10):3662-72
references.pmid: 17652622
references.citation: Neurosci Lett. 2005 Dec 23;390(2):81-6
references.pmid: 16139428
references.citation: Lab Invest. 1994 Oct;71(4):583-94
references.pmid: 7967513
references.citation: Circ Res. 2008 Jul 3;103(1):4-6
references.pmid: 18596260
references.citation: J Exp Clin Cancer Res. 2004 Sep;23(3):529-38
references.pmid: 15595646
references.citation: Biochem Pharmacol. 2006 Nov 30;72(11):1577-88
references.pmid: 16854382
references.citation: World J Gastroenterol. 2004 May 1;10(9):1246-9
references.pmid: 15112336
references.citation: Int J Oncol. 2002 Nov;21(5):1033-40
references.pmid: 12370752
references.citation: Cell Prolif. 2008 Feb;41(1):28-35
references.pmid: 18211284
references.citation: Urol Res. 1995;23(5):293-300
references.pmid: 8839385
references.citation: Anticancer Res. 2007 Sep-Oct;27(5A):3279-84
references.pmid: 17970071
references.citation: Mol Biol Cell. 2007 Jul;18(7):2630-5
references.pmid: 17494866
references.citation: Exp Cell Res. 2004 Sep 10;299(1):159-70
references.pmid: 15302583
references.citation: Circ Res. 2008 Jul 3;103(1):89-97
references.pmid: 18519946
references.citation: J Cell Biochem. 2003 Aug 15;89(6):1235-49
references.pmid: 12898521
references.citation: Int J Cancer. 2006 Oct 1;119(7):1513-8
references.pmid: 16557569
references.citation: J Cell Physiol. 2001 May;187(2):155-65
references.pmid: 11267995
references.citation: Genes Chromosomes Cancer. 2003 Jun;37(2):141-8
references.pmid: 12696062
references.citation: J Cancer Res Clin Oncol. 2006 Jul;132(7):417-26
references.pmid: 16456675
references.citation: Genes Dev. 2002 Dec 1;16(23):2991-3003
references.pmid: 12464630